Exploitation of the bulgarian flora's biodiversity as a source of immunomodulatory and/or antineoplastic agents: Current challenges and perspectives

Biotechnology and Biotechnological Equipment

Volumn 21, Issue 4, 2007, Pages 471-477

  Nikolov, S ^a   Momekov, G ^a   Kitanov, G ^a   Ionkova, I ^a   Krasteva, I ^a   Toshkova, R ^b   Konstantinov, S ^a   Nedialkov, P ^a   Karaivanova, M ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

Author keywords

Antineoplastic; Benzophenones; Hypericum spp; Immunomodulatory; Lignans; Linum spp. phloroglucinols; Mulri drug resistance; Podophyllotoxin; Saponins

Indexed keywords

HYPERICUM; LINUM; THALICTRUM;

EID: 37749007122     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.1080/13102818.2007.10817497     Document Type: Article

References (43)

1. Basu S., Ma R., Boyle P.J., Mikulla B., Bradley M., Smith B., Basu M., Banerjee S., (2004) Glycoconj. J., 20 563–577.
2. Chabner B.A., Amrein P.C., Druker B.J., Michaelson D., Mitsiades C.S., Goss P.E., Ryan D.P., Ramachandra S., Richardson P.G., Supko J.G., Wilson W.H., (2006) In:Goodman & Gilman's The pharmacological basis of therapeutics, (L.L., Brunton, J.S., Lazo and K.L., Parker Eds), McGraw Hill, New York, 1315–1403.
3. Chintharlapalli S., Papineni S., Ramaiah S.K., Safe S., (2007) Cancer. Res., 67 2816–2823.
4. Cichewicz R.H., Kouzi S.A., (2004) Med. Res. Rev., 24 90–114.
5. Dolle, R.E., (2003) J. Combinator. Chem., 5 693–753.
6. Dona M., Dell'Aica I., Pezzato E., Sartor L., Calabrese F., Della Barbera M., Donella-Deana A., Appendino G., Borsarini A., Caniato R., Garbisa, S., (2004) Cancer Res., 64 6225–6232.
7. Eder-Czembirek C., Czembirek C., Erovic B.M., Selzer E., Turhani D., Vormittag L., Thurnher D., (2005) Oncol. Rep., 14 667–671.
8. Galgon T., Wohlrab W., Drager B., (2005) Exp. Dermatol., 14 736–743.
9. Giacomini K.M., Sugiyama, Y., (2006) In:Goodman & Gilman's The pharmacological basis of therapeutics, (L. L., Brunton, J. S., Lazo and K. L., Parker, eds.), McGraw Hill, New York, 41–71.
10. Hande K. R., (1998) Eur. J. Cancer, 34 1514–1522.
11. Horvath L.E., Konstantinov S.M., Ilarionova M.V., Todorov D.K., (2004) Fitoterapia, 75 712–717.
12. Ionkova I., (2007) Phcog. Mag, 1 57–68.
13. Ionkova I., Antonova I., Momekov G., Fuss E., (2007) Phcog. Mag, 1 193–195.
14. Itri L.M., Gralla R.J., (1982) Cancer Treat. Rev., 9 Suppl 115–118.
15. Jung G. R., Kim K. J., Choi C. H., Lee T. B., Han S. I., Han H. K., Lim S. C., (2007) Basic. Clin. Pharmacol. Toxicol., 101 277–285.
16. Kessler J. H., Mullauer F. B., de Roo G. M., Medema J. P., (2007) Cancer Lett., 251 132–145.
17. Kitanov G.M., (2001) Biochem. Syst. Ecol., 29 171–178.
18. Koulman A., Quax W.J., Pras N., (2004) In:Biotechnology of medicinal plants:vitalizer and therapeutic (R. K.G., Ed), Science Publishers Inc., Plymouth (UK), Enfield (USA), 225–266.
19. Krasteva I., Nikolov S., Kaloga M., Mayer G., (2006) Z. Naturforsch., 61b 1166–1169.
20. Krasteva I., Nikolov S., Kaloga M., Mayer G., (2007) Nat. Prod. Res., 21 941–945.
21. Krasteva I., Platikanov S., Momekov G., Konstantinov S., Nikolov S., (2007) Nat. Prod. Res. (In press).
22. Krasteva I.N., Toshkova R.A., Nikolov S.D., (2004) Phytother. Res., 18 255–257.
23. Krensky A.M., Vincenti F., Bennett W.M., (2006) In:Goodman & Gilman's The pharmacological basis of therapeutics, (L.L., Brunton, J.S., Lazo and K.L., Parker, eds.), McGraw Hill, New York, 1405–1431.
24. Mircheva J., Stoychkov J., (1976) Biomedicine, 25 280–281.
25. Momekov G., Nedialkov P.T., Kitanov G.M., Zheleva- Dimitrova D., Tzanova T., Girreser U., Karaivanova M., (2006) Med. Chem., 2 377–384.
26. Momekov G., Krasteva I., Platikanov S., Nikolov S., Konstantinov S., (2007) Compt. Rend. de l'Acad. Bulg. Sci. (In press).
27. Nedialkov P.T., Kitanov G.M., (2002) Phytochemistry, 59 867–871.
28. Nedialkov P.T., Zheleva-Dimitrova D., Girreser U., Kitanov G.M., (2007) Nat. Prod. Res., 21 1056–1060.
29. Petersen M., Alfermann A.W., (2001) Appl. Microbiol. Biotechnol., 55 135–142.
30. Phillips N.C., Lauper R.D., (1983) Clin. Pharm., 2 112–119.
31. Quiney C., Billard C., Salanoubat C., Fourneron J.D., Kolb J.P., (2006) Leukemia, 20 1519–1525.
32. Rzeski W., Stepulak A., Szymanski M., Sifringer M., Kaczor J., Wejksza K., Zdzisinska B., Kandefer-Szerszen M., (2006) Naunyn Schmiedebergs Arch. Pharmacol., 374 11–20.
33. Stoychkov J.N., Miloushev A.S., (1980) Biomedicine, 33 42–44.
34. Thurnher D., Turhani D., Pelzmann M., Wannemacher B., Knerer B., Formanek M., Wacheck V., Selzer E., (2003) Head Neck, 25 732–740.
35. Todorov D.K., Deliconstantinos G., (1982) Experimentia, 38 857–859.
36. Toshkova R.A., Krasteva I.N., Wesselinova D.W., Nikolov S.D., (2007) J. Ethnopharmacol., 109 394–399.
37. van Maanen J.M., Retel J., de Vries J., Pinedo H.M., (1988) J. Natl. Cancer Inst., 80 1526–1533.
38. Vasilev N., Ionkova I., (2004) Acta Pharm., 54 347–351.
39. Vasilev N., Momekov G., Zaharieva M., Konstantinov S., Bremner P., Heinrich M., Ionkova I., (2005) Neoplasma, 52 425–429.
40. Vasilev N., Elfahmi, Bos R., Kayser O., Momekov G., Konstantinov S., Ionkova I., (2006) J. Nat. Prod., 69 1014–1017.
41. Vasilev N.P., Ionkova I., (2005) Fitoterapia, 76 50–53.
42. Vasilev N.P., Julsing M. K., Koulman A., Clarkson C., Woerdenbag H.J., Ionkova I., Bos R., Jaroszewski J.W., Kayser O., Quax W.J., (2006) J. Biotechnol., 126 383–393.
43. CITES Secretariat/World Conservation Monitoring Centre (2001) World Conservation Monitoring Centre Checklist of CITES species:a reference to the appendices to the Convention on international trade in endangered species of wild fauna and flora, Chelataine-Geneve.